Edition:
United Kingdom

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

1.84USD
17 Jul 2019
Change (% chg)

-- (--)
Prev Close
$1.84
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
406,411
52-wk High
$9.19
52-wk Low
$1.56

About

Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5), including paroxysmal nocturnal... (more)

Overall

Beta: -2.81
Market Cap(Mil.): $35.11
Shares Outstanding(Mil.): 0.19
Dividend: --
Yield (%): --

Financials

  AKTX.OQ Industry Sector
P/E (TTM): -- 96.93 34.10
EPS (TTM): -1.14 -- --
ROI: -200.40 7.71 12.64
ROE: -201.47 8.16 17.18

Earnings vs. Estimates